Vetera® GoldXP
Combination Vaccine for Horses
-
VETERA® GOLDXP is the industry's #1 vaccine1
-
VETERA® GOLDXP has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against:
-
Eastern and western encephalomyelitis (EEE & WEE)
-
West nile virus (WNV)
-
Tetanus
-
Respiratory disease due to equine herpes virus types 1 and 4 (EHV-1 & EHV-4)
-
Equine influenza virus (EIV)
-
-
VETERA® GOLDXP has also been shown to be effective against viral shedding due to A2 EIV and against viremia, mortality, and neurological clinical disease due to WNV
-
The VETERA® portfolio features a wide range of progressive choices and contains the most comprehensive 1 mL vaccine (VETERA® GOLDXP + VEE) on the US market
-
VETERA® was the first vaccine in the US updated to contain both Florida sublineage clade 1 and clade 2 EIV, as recommended by the Expert Surveillance Panel (OIE) on Equine Influenza and AAEP
Features
-
Contains a combination of various antigens in one vaccine
-
Influenza
-
Herpesvirus types 1 and 4 (EHV-1 and EHV-4)
-
West Nile Virus (WNV)
-
Eastern and Western Equine Encephalomyelitis (EEE and WEE)
-
Tetanus
-
-
Contains Kentucky lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains
-
Contains EHV-1 and EHV-4
-
Includes a unique North American Equine E159™ WNV strain
-
Incorporates the Carbimmune® adjuvant formulation
-
Ultrafil® purification technology
Benefits
-
7-way protection in one vaccine
-
Carbimmune® adjuvant system allows a dual-phase antigen presentation to deliver both rapid and long-lasting immunity
-
Ultrafil® purification technology eliminates undesirable cellular components and extraneous protein to minimize the potential injection site reactions (such as heat, swelling, and inflammation)
-
At least 6-month duration of immunity against EIV (OH/03)
-
At least 12-month WNV duration of immunity
-
Safe for use in horses as young as 4 months of age, including pregnant mares
Shake well before use. Using aseptic technique, inoculate horses intramuscularly (IM) with a 1 mL dose.
Administer a second 1mL dose intramuscularly in 3-4 weeks using a different injection site.
The need for annual booster vaccination has not been established for this product. Consultation with a veterinarian for revaccination frequency should be considered.
Precautions
-
Store at at 35-46°F (2-8°C)
-
Do not freeze
-
Do not mix with other products
-
Do not vaccinate within 21 days before slaughter
-
Use entire contents when first opened
In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.
- Ceesa vaccines data. July, 2021.
VETERA® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license. ULTRAFIL® and CARBIMMUNE® are registered trademarks of Boehringer Ingelheim Animal Health USA, Inc. ©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0104-2021